Skip to main content
. 2023 Feb 10;26(4):759–764. doi: 10.1038/s41391-022-00638-y

Table 5.

Comparison of unadjusted ten-year oncologic survival outcomes between men with a delayed detectable PSA for 3348 patients who underwent radical prostatectomy at University of California, San Francisco.

Outcome Salvage Treatment
Yes No p-value
Metastasis-free survival 86% 97% <0.01
Prostate cancer-specific mortality 5% 1% 0.05
All-cause mortality 7% 5% 0.53